Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - rifampicinum - kapseln - rifampicinum 300 mg, calcii stearas, lactosum 50 mg, kapselhülle: gelatina, e 171, e 172 (rubrum), e 172 (flavum), e 172 (nigrum), drucktinte: lacca, e 172 (nigrum), pro capsula. - tuberkulose und andere infektionskrankheiten - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - amiodaroni hydrochloridum - injizierbare lösung - amiodaroni hydrochloridum 50 mg, polysorbatum 80, conserv.: alcohol benzylicus 20 mg, wasser q.s. zu einer lösung anstelle von 1 ml. - antiarythmique - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - rifampicinum - kapseln - rifampicinum 150 mg, cellulosum microcristallinum, lactosum monohydricum 10 mg, natrii laurilsulfas, silica colloidalis anhydrica, carboxymethylamylum natricum a, talcum, magnesii stearas, matériel de la capsule: gelatina, e 171, e 172 (rubrum), pro capsula corresp. natrium max. 0.66 mg. - tuberculostatique - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - rifampicinum - kapseln - rifampicinum 300 mg, cellulosum microcristallinum, lactosum monohydricum 13 mg, natrii laurilsulfas, silica colloidalis anhydrica, carboxymethylamylum natricum a, talcum, magnesii stearas, matériel de la capsule: gelatina, e 171, e 172 (rubrum), e 172 (nigrum), encre: lacca, e 171, pro capsula corresp. natrium max. 0.9 mg. - tuberculostatique - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - amiodaroni hydrochloridum - injizierbare lösung - amiodaroni hydrochloridum 50 mg, polysorbatum 80, alcohol benzylicus 20.2 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - antiarythmique - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - rifampicinum - filmtabletten - rifampicinum 450 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, silica colloidalis anhydrica, sorbitolum 289.875 mg, pellicule: hypromellosum, macrogolum 6000, propylenglycolum, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium max. 5.06 mg. - tuberculose et autres maladies infectieuses - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

labatec pharma sa - rifampicinum - filmtabletten - rifampicinum 600 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, silica colloidalis anhydrica, sorbitolum 386.5 mg, pellicule: hypromellosum, macrogolum 6000, propylenglycolum, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium max. 6.75 mg. - tuberculose et autres maladies infectieuses - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - sofosbuvirum, velpatasvirum, voxilaprevirum - filmtabletten - sofosbuvirum 400 mg, velpatasvirum 100 mg, voxilaprevirum 100 mg, copovidonum, lactosum monohydricum 116.6 mg, cellulosum microcristallinum, carmellosum natricum nur zusammengehalten endwerte. natrium 9.884 mg, silica colloidalis anhydrica, magnesium stearas, Überzug: poly(alkohol vinylicus), macrogolum 3350, talkum, e 171, e 172 (gelb), e 172 (rot) e 172 (schwarz), für compresso dunst. - chronische hepatitis c - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - darunavirum, cobicistatum, emtricitabinum, tenofovirum alafenamidum - filmtabletten - darunavirum 800 mg ut darunavirum ethanolum, cobicistatum 150.0 mg, silica colloidalis anhydrica, emtricitabinum 200.0 mg, tenofovirum alafenamidum 10 mg ut tenofoviri alafenamidi hemifumaras, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: macrogolum 4000, talcum, poly(alcohol vinylicus), e 171, e 172 (flavum), pro compresso obducto corresp. natrium 3.47 mg. - hiv-infektion - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

viiv healthcare gmbh - lamivudinum, dolutegravirum - filmtabletten - lamivudinum 300 mg, dolutegravirum 50 mg ut dolutegravirum natricum, excipiens pro compresso obducto. - hiv-1 infektion - synthetika